Pharmaceutical Industry Shifts Focus to Oral Weight-Loss Medications

The pharmaceutical sector is increasingly optimistic about the future of weight-loss treatments, with a significant shift from injectable medications to more accessible pill forms, potentially expanding the market to $200 billion by the decade's end.